Filing metadata

Accession number
0001415889-22-012650
Form type
Form 4
Filer
NRX Pharmaceuticals, Inc.
CIK
CIK 1719406
Filed
Dec 19, 2022
Reporting period
Nov 25, 2022
Description
Insider transaction

Explore SEC Filings Hub